eN-Lac®
MA0809005101
Phase 3 mab completed
Quick answer
eN-Lac® for Perennial Allergic Rhinitis is a Phase 3 program (mab) at Biotech Pharmaceutical Co., with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Biotech Pharmaceutical Co.,
- Indication
- Perennial Allergic Rhinitis
- Phase
- Phase 3
- Modality
- mab
- Status
- completed